Outcome
bleeding, arrhythmia, seizures, ischemia, OHCA, infection, mitochondrial dysfunction
BLEEDING, ARRHYTHMIA, ADVERSE EVENTS, ISCHEMIA, INFECTION, MITOCHONDRIAL DYSFUNCTION, COMPLICATIONS
The primary outcome was the difference between time-averaged means of microdialysis parameters and LP ratio (intervals of 12 h) between low vs high MAP group within 96 h of post-resuscitation care. Secondary outcomes of clinical interest were to compare (i) variables reflecting cerebral energy metabolism and patterns of ischemia and mitochondrial dysfunction in patients with unfavorable and favorable neurological outcome [Neurological outcome was assessed at hospital discharge and 90 days after OHCA according to the Cerebral Performance Category (CPC) scale [The adverse events included in this report are bleeding, infection, arrhythmia, and seizures as well as complications related to the MD technique.